다우존스 지수

실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

등록

홈
인베스팅
주식
영국
LSE
Moberg Pharma Ab (publ) (0P48)
Moberg Pharma Ab (publ) (0P48) 뉴스

0P48

Moberg Pharma Ab (publ) (0P48)

Moberg Pharma Ab (publ)

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:LSE:0P48

1 2 3 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/02/07	16:12	UK Regulatory	MOB-015 is launched in Sweden under the brand name Terclara- pharmacies report major demand for the new medication	LSE:0P48	Moberg Pharma Ab (publ)
2024/02/07	16:10	UK Regulatory	MOB-015 is launched in Sweden under the brand name Terclara- pharmacies report major demand for the new medication	LSE:0P48	Moberg Pharma Ab (publ)
2023/06/28	18:23	PR Newswire (US)	MOB-015 is recommended for approval in EU: Moberg Pharma	LSE:0P48	Moberg Pharma Ab (publ)
2022/03/28	15:10	PR Newswire (US)	European marketing authorization application for MOB-015 submitted	LSE:0P48	Moberg Pharma Ab (publ)
2021/12/23	16:12	PR Newswire (US)	The Medical Products Agency in Sweden will be reference member state for Moberg Pharma's European registration application	LSE:0P48	Moberg Pharma Ab (publ)
2021/09/22	15:22	PR Newswire (US)	Moberg Pharma receives approval from the EMA's Paediatric Committee	LSE:0P48	Moberg Pharma Ab (publ)
2021/02/09	16:13	PR Newswire (US)	Moberg Pharmas Year-end report 2020	LSE:0P48	Moberg Pharma Ab (publ)
2021/01/29	21:23	PR Newswire (US)	Moberg Pharma: Announcement of terms for the fully guaranteed rights issue in OncoZenge, timetable for the listing and record...	LSE:0P48	Moberg Pharma Ab (publ)
2021/01/29	16:37	PR Newswire (US)	New number of shares and votes in Moberg Pharma AB (publ)	LSE:0P48	Moberg Pharma Ab (publ)
2021/01/07	16:08	PR Newswire (US)	OncoZenge announces issue of European Patent related to BupiZenge®	LSE:0P48	Moberg Pharma Ab (publ)
2020/12/11	16:07	PR Newswire (US)	OncoZenge raises MSEK 10 ahead of spin-off and separate listing	LSE:0P48	Moberg Pharma Ab (publ)
2020/11/30	22:33	PR Newswire (US)	Moberg Pharma obtains positive decision from the Swedish Tax Agency regarding the Lex Asea distribution of the shares in Onco...	LSE:0P48	Moberg Pharma Ab (publ)
2020/11/23	16:41	PR Newswire (US)	Invitation to market update in Moberg Pharma on November 25th	LSE:0P48	Moberg Pharma Ab (publ)
2020/11/16	23:16	PR Newswire (US)	OncoZenge secures approximately SEK 70 million in financing ahead of spin-off and separate listing	LSE:0P48	Moberg Pharma Ab (publ)
2020/11/10	17:02	PR Newswire (US)	Extended fiscal year July 2019 - December 2020 Interim report July - September 2020	LSE:0P48	Moberg Pharma Ab (publ)
2020/11/06	16:26	PR Newswire (US)	Moberg Pharma decides on fully guaranteed rights issue of approximately SEK 150 million	LSE:0P48	Moberg Pharma Ab (publ)
2020/11/06	16:25	PR Newswire (US)	Moberg Pharma intends to distribute and separately list BupiZenge® (BUPI)	LSE:0P48	Moberg Pharma Ab (publ)
2020/10/14	15:27	PR Newswire (US)	Moberg Pharma intends to submit a registration application in Europe in 2021	LSE:0P48	Moberg Pharma Ab (publ)
2020/10/14	15:24	PR Newswire (US)	Moberg Pharma intends to submit a registration application in Europe in 2021	LSE:0P48	Moberg Pharma Ab (publ)
2020/08/11	15:16	PR Newswire (US)	Moberg Pharma: Interim report April - June 2020	LSE:0P48	Moberg Pharma Ab (publ)
2020/07/30	15:27	PR Newswire (US)	Appointment of Chief Medical Officer at Moberg Pharma	LSE:0P48	Moberg Pharma Ab (publ)
2020/06/30	15:28	PR Newswire (US)	New number of Shares and Votes in Moberg Pharma AB (publ)	LSE:0P48	Moberg Pharma Ab (publ)
2020/06/25	15:26	PR Newswire (US)	Moberg Pharma Meets Primary Endpoint in the European Phase 3 Study	LSE:0P48	Moberg Pharma Ab (publ)
2020/06/25	15:23	PR Newswire (US)	Moberg Pharma Meets Primary Endpoint in the European Phase 3 Study	LSE:0P48	Moberg Pharma Ab (publ)
2020/05/29	15:13	PR Newswire (US)	New Number of Shares and Votes in Moberg Pharma AB (publ)	LSE:0P48	Moberg Pharma Ab (publ)
2020/05/12	15:24	PR Newswire (US)	Extended Fiscal Year July 2019 - December 2020 Interim Report January - March 2020	LSE:0P48	Moberg Pharma Ab (publ)
2020/05/05	15:14	PR Newswire (US)	Moberg Pharma's Interim Report for July 2019 - March 2020 to be Published on May 12 - Invitation to Teleconference	LSE:0P48	Moberg Pharma Ab (publ)
2020/03/27	17:20	PR Newswire (US)	Notice of Extraordinary General Meeting in Moberg Pharma AB (publ)	LSE:0P48	Moberg Pharma Ab (publ)
2020/03/24	05:17	PR Newswire (US)	Moberg Pharma Enters Financing Agreement of Up To SEK 216 Million for Further Investments in MOB-015	LSE:0P48	Moberg Pharma Ab (publ)
2020/02/11	16:18	PR Newswire (US)	Moberg Pharma AB Interim Report October - December 2019	LSE:0P48	Moberg Pharma Ab (publ)

검색 관련기사 보기:LSE:0P48

1 2 3 다음 >>

Gold vs US Dollar

Bank of America

Invesco QQQ Trust Series 1

US Dollar vs Euro

Deutsche Telekom (QX)

Energy Select Sector SPDR

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관